Company / Financials
SOLENO THERAPEUTICS INC Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
-
FY2025
Net Income
$20.9M
FY2025 · +111.9% YoY
Profit Margin
-
FY2025 · net income / revenue
ROE
4.6%
FY2025 · return on equity
Total Assets
$563.8M
FY2025
Total Debt
$49.9M
0.11x debt/equity
Equity
$450.1M
FY2025
ROA
3.7%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.5MNet Income HistoryProfit after all expenses and taxes$20.9M+111.9% YoYGross Profit HistoryRevenue minus cost of goods sold-$58.5KCost of Revenue HistoryDirect costs of producing goods and services sold$2.7MOperating Income HistoryProfit from core business operations before interest and taxes$9.4M+105.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$132.1M+24.8% YoYR&D Expense HistoryResearch and development spending$40.6M-48.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$5.5M+2270.6% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share$0.40+109.1% YoY